Trusted access to medicines, worldwide.
Comparator sourcing, named-patient supply, clinical-trials logistics and contract manufacturing — delivered worldwide under WHO GDP-certified cold-chain conditions.
Services
Built for sponsors, hospitals and procurement teams
Seven integrated services that solve sourcing, regulatory and logistics problems for clinical and commercial pharma supply.
Comparator sourcing
Reference-listed drug and active comparator supply for clinical trials across global markets.
Clinical trials supply
End-to-end IMP sourcing, kitting and depot-to-site logistics for sponsors and CROs.
Named patient supply
Compliant supply of unlicensed or hard-to-find medicines for individual patients.
Contract manufacturing
Toll and contract manufacturing partnerships with vetted, regulator-approved facilities.
Dossiers & stability
Regulatory dossiers, stability programs and lifecycle documentation support.
Validated cold-chain
Qualified shipping lanes, validated containers and continuous temperature monitoring.
Competitive pricing
Direct-from-manufacturer pricing with transparent cost build-ups and forecasting.
Catalog
Featured products across regulator-approved registers
Recently updated items across the regional drug registers we serve worldwide.
Prevymis 480 mg
Letermovir · 480 MG
Prevymis 240 mg
Letermovir · 240 MG
WEGOVY .25 mg/.5mL
Semaglutide · 0.25 mg/0.5 mL
WEGOVY .25 mg/.5mL
Semaglutide · 0.25 mg/0.5 mL
PREVYMIS 480 mg/1
Letermovir · 480 mg
PREVYMIS 480 mg/1
Letermovir · 480 mg
PREVYMIS 240 mg/1
Letermovir · 240 mg
PREVYMIS 240 mg/1
Letermovir · 240 mg
Worldwide reach
We source and supply worldwide
Our online catalog is searchable by two regulator-approved registers — USA (NDC) and Europe (EMA) — but our sourcing and named-patient supply reach far beyond them: from 60+ countries to wherever you need delivery.
Talk to sourcing
Need a specific molecule, brand or batch?
Share your protocol, target market and timelines. Our sourcing team responds within one business day with availability, lead time and indicative pricing.